Project

Combination of ibrutinib and bortezomib followed by ibrutinib maintenance to treat patients with relapsed and refractory mantle cell lymphoma; a multicenter Phase I/II trial

Automatically Closed · 2015 until 2021

Driessen Christoph, Hitz Felicitas, Fehr Martin, Hess Urs, Hess Dagmar, Silzle Tobias